Indications
This medicinal product is for diagnostic use only.For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, incombination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.
Composition
- Active substance
- depreotide trifluoroacetate
- International name (INN)
- depreotide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- NeoSpect
- Active substance
- depreotide trifluoroacetate
- ATC code
- V09IA05
- Group
- Various
- Therapeutic area
- Radionuclide Imaging
- Marketing authorisation holder
- CIS bio international